Teva Pharmaceutical Industries Ltd (TEVA.N)

TEVA.N on New York Stock Exchange

61.56USD
2 Jul 2015
Change (% chg)

$0.61 (+1.00%)
Prev Close
$60.95
Open
$60.95
Day's High
$61.62
Day's Low
$60.88
Volume
989,593
Avg. Vol
930,689
52-wk High
$68.74
52-wk Low
$47.37

TEVA.N

Chart for TEVA.N

About

Teva Pharmaceutical Industries Ltd (Teva) is an Israel-based pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. Teva’s active pharmaceutical ingredient (API) business... (more)

Overall

Beta: 0.63
Market Cap(Mil.): $58,891.82
Shares Outstanding(Mil.): 959.35
Dividend: 0.34
Yield (%): 2.19

Financials

  TEVA.N Industry Sector
P/E (TTM): 19.16 35.83 39.81
EPS (TTM): 3.21 -- --
ROI: 7.88 17.03 16.23
ROE: 12.09 17.93 17.36
Search Stocks

Deals of the day- Mergers and acquisitions

July 1 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

02 Jul 2015

Teva and Philips to jointly invest in Israeli medical device firms

TEL AVIV - Teva Pharmaceutical Industries and Philips are together investing up to 100 million shekels ($26.5 million) over eight years in medical device and health technology start-ups in Israel.

01 Jul 2015

Teva and Philips to jointly invest in Israeli medical device firms

TEL AVIV, July 1 - Teva Pharmaceutical Industries and Philips are together investing up to 100 million shekels ($26.5 million) over eight years in medical device and health technology start-ups in Israel.

01 Jul 2015

Deals of the day- Mergers and acquisitions

June 19 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

20 Jun 2015

Teva raises stake in Mylan as three-way takeover battle heats up

- Israel's Teva Pharmaceutical Industries Ltd has raised its stake in Mylan N.V. to the 4.61 percent needed for it to legally challenge Mylan's rejection of Teva's hostile takeover offer under Dutch law.

19 Jun 2015

Teva raises stake in Mylan as three-way takeover battle heats up

June 19 - Israel's Teva Pharmaceutical Industries Ltd has raised its stake in Mylan N.V. to the 4.61 percent needed for it to legally challenge Mylan's rejection of Teva's hostile takeover offer under Dutch law.

19 Jun 2015

U.S. appeals court again invalidates Teva's MS drug patent

NEW YORK - A U.S. appeals court on Thursday once again invalidated a patent held by Teva Pharmaceutical Industries Ltd on its top-selling multiple sclerosis drug Copaxone, clearing the way for the launch of a cheaper, generic version.

18 Jun 2015

UPDATE 2-U.S. appeals court again invalidates Teva's MS drug patent

NEW YORK, June 18 - A U.S. appeals court on Thursday once again invalidated a patent held by Teva Pharmaceutical Industries Ltd on its top-selling multiple sclerosis drug Copaxone, clearing the way for the launch of a cheaper, generic version.

18 Jun 2015

Abbott to vote for Mylan's acquisition of Perrigo

- Mylan NV's largest stakeholder, Abbott Laboratories , said it would back Mylan's proposed acquisition of Perrigo Co Plc , potentially helping Mylan fend off interest from Teva Pharmaceutical Industries Ltd .

17 Jun 2015

REFILE-UPDATE 1-Abbott to vote for Mylan's acquisition of Perrigo

June 16 - Mylan NV's largest stakeholder, Abbott Laboratories, said it would back Mylan's proposed acquisition of Perrigo Co Plc, potentially helping Mylan fend off interest from Teva Pharmaceutical Industries Ltd .

16 Jun 2015

Competitors

  Price Chg
Novartis AG (NOVN.VX) CHF93.05 -0.85
Biogen Inc (BIIB.OQ) $404.28 -1.13

Earnings vs. Estimates

Search Stocks